Fisher & Paykel Healthcare Corporation Ltd
OTC:FSPKF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
OTC:FSPKF
|
NZ |
|
R
|
Realty Income Corp
XMUN:RY6
|
US |
|
Intesa Sanpaolo SpA
MIL:ISP
|
IT |
|
A
|
Advanced Micro Devices Inc
F:AMD
|
US |
|
Relief Therapeutics Holding SA
OTC:RLFTY
|
CH |
|
Great Panther Mining Ltd
TSX:GPR
|
CA |
|
N
|
NRG Energy Inc
F:NRA
|
US |
|
A
|
AVEVA Group PLC
F:4A91
|
UK |
|
S
|
SolGold PLC
F:S8F
|
AU |
|
T
|
Toyota Industries Corp
XMUN:TAH
|
JP |
|
ACS Actividades de Construccion y Servicios SA
MAD:ACS
|
ES |
|
M
|
MGIC Investment Corp
BMV:MTG
|
US |
|
Wartsila Oyj Abp
F:MTA
|
FI |
|
O
|
Oversea-Chinese Banking Corporation Ltd
XMUN:OCBA
|
SG |
|
N
|
NRG Energy Inc
XMUN:NRA
|
US |
|
PRO Real Estate Investment Trust
OTC:PRVFF
|
CA |
|
A
|
Abbott India Ltd
BSE:500488
|
IN |
|
C
|
CureVac NV
XBER:5CV
|
DE |
|
A
|
Azimut Holding SpA
XBER:HDB
|
IT |
|
Arcelormittal South Africa Ltd
OTC:ARCXF
|
ZA |
|
G
|
GS Yuasa Corp
DUS:G9Y
|
JP |
|
Adobe Inc
NASDAQ:ADBE
|
US |
|
Diageo PLC
LSE:DGED
|
UK |
|
Longfor Group Holdings Ltd
HKEX:960
|
CN |
Wall St Price Targets
FSPKF Price Targets Summary
Fisher & Paykel Healthcare Corporation Ltd
According to Wall Street analysts, the average 1-year price target for FSPKF is 26.88 USD with a low forecast of 23.08 USD and a high forecast of 31.32 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FSPKF's stock price target?
Price Target
26.88
USD
According to Wall Street analysts, the average 1-year price target for FSPKF is 26.88 USD with a low forecast of 23.08 USD and a high forecast of 31.32 USD.
What is the Revenue forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 20%.
